Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan

Ikezoe, T; Ando, K; Onozawa, M; Yamane, T; Hosono, N; Morita, Y; Kiguchi, T; Iwasaki, H; Miyamoto, T; Matsubara, K; Sugimoto, S; Miyazaki, Y; Kizaki, M; Akashi, K

Ikezoe, T (通讯作者)，Fukushima Med Univ Hosp, Dept Hematol, Fukushima, Japan.

CANCER SCIENCE, 2022; 113 (12): 4258

Abstract

Therapeutic improvements are needed for patients with acute myeloid leukemia (AML), particularly those who have relapsed or who have treatment-refract......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索